|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's range||1.7700 - 1.7700|
|52-week range||1.3700 - 2.5500|
|Beta (5Y monthly)||0.39|
|PE ratio (TTM)||6.32|
|Forward dividend & yield||0.54 (25.88%)|
|Ex-dividend date||01 Jun 2021|
|1y target est||N/A|
Philip Morris (PM) secures more than 74% of Vectura's shares to become a majority stakeholder. The company expects to amplify growth in its Beyond Nicotine strategy via this move.
British inhaler developer Vectura has been barred from a major medical conference amid a growing backlash over its £1bn takeover by tobacco giant Philip Morris International.
Inhaler firm Vectura removed from conference over Philip Morris takeover. Academics object to UK company’s sponsorship of pharmaceutical event after tobacco giant seals £1.1bn deal